Ateb announces PQA appointments for 2015

RALEIGH, N.C. — Ateb, a provider of pharmacy patient care solutions, on Monday announced the appointments of four Ateb pharmacists to the Pharmacy Quality Alliance’s measure development teams and stakeholder advisory panels for 2015.

 

The Pharmacy Quality Alliance is a nonprofit that promotes appropriate medication use and develops strategies for safety performance measures. According to Ateb, the PQA is recognized for its development of metrics as it relates to safe medication use, with many of its measures being used by the Centers for Medicare and Medicaid Services for the Medicare Part D and Medicare Advantage Prescription Drug Program.

 

“Once again this year, Ateb will play an important role in the measure developments of the Pharmacy Quality Alliance,” said Frank Sheppard, founder and CEO of Ateb. “Ateb’s appointments to the PQA measure development teams, as well as contributions to the stakeholder advisory panels, reflect the outstanding reputation of Ateb’s pharmacists and Ateb’s commitment to the industry. These measures developed by the PQA teams are used for Star Ratings, and our pharmacies and healthcare payers will greatly benefit from Ateb’s ongoing alignment with the PQA.”

 

Ateb was granted the maximum number of appointments to PQA measurement development teams this year. The teams are comprised of PQA members who applied to work on specific measures based on their individual strengths and experience. The Ateb pharmacists and their positions are: 

 

Appointee: Mark Gregory, RPh

Ateb Position: VP Health Solutions

MDT #3: MTM-Part D: Use of Patient Satisfaction Survey following CMR Completion

 

Appointee: Robb Ayshford, RPh, MBA

Ateb Position: VP Chain Strategic Solutions

MDT #5: Primary Medication Non-Adherence (PMN) - For Health Plans

 

Appointee: Rebecca Chater, RPh, MPH, FAPhA

Ateb Position: Executive Healthcare Strategist

MDT #6: Hospital and/or ED Utilization Related to ADEs

 

Appointee: Bob Mernar, RPh

Ateb Position: Privacy Officer

MDT #9: MTM-Part D: Specific Drug Therapy Problem (DTP) Resolution

 

Chater also was appointed to the PQA Immunization Task Force and will co-chair Stakeholder Advisory Panel C.